全文获取类型
收费全文 | 1446篇 |
免费 | 94篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 64篇 |
妇产科学 | 126篇 |
基础医学 | 141篇 |
口腔科学 | 38篇 |
临床医学 | 136篇 |
内科学 | 272篇 |
皮肤病学 | 14篇 |
神经病学 | 34篇 |
特种医学 | 168篇 |
外科学 | 129篇 |
综合类 | 168篇 |
一般理论 | 1篇 |
预防医学 | 76篇 |
眼科学 | 11篇 |
药学 | 59篇 |
中国医学 | 4篇 |
肿瘤学 | 122篇 |
出版年
2023年 | 3篇 |
2022年 | 24篇 |
2021年 | 30篇 |
2020年 | 22篇 |
2019年 | 21篇 |
2018年 | 37篇 |
2017年 | 29篇 |
2016年 | 29篇 |
2015年 | 47篇 |
2014年 | 85篇 |
2013年 | 82篇 |
2012年 | 98篇 |
2011年 | 75篇 |
2010年 | 55篇 |
2009年 | 60篇 |
2008年 | 82篇 |
2007年 | 49篇 |
2006年 | 62篇 |
2005年 | 47篇 |
2004年 | 41篇 |
2003年 | 61篇 |
2002年 | 41篇 |
2001年 | 31篇 |
2000年 | 20篇 |
1999年 | 24篇 |
1998年 | 36篇 |
1997年 | 36篇 |
1996年 | 38篇 |
1995年 | 36篇 |
1994年 | 31篇 |
1993年 | 21篇 |
1992年 | 9篇 |
1991年 | 9篇 |
1990年 | 14篇 |
1989年 | 19篇 |
1988年 | 27篇 |
1987年 | 22篇 |
1986年 | 24篇 |
1985年 | 18篇 |
1984年 | 14篇 |
1983年 | 13篇 |
1982年 | 6篇 |
1981年 | 12篇 |
1980年 | 6篇 |
1979年 | 3篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1973年 | 3篇 |
1969年 | 3篇 |
1893年 | 2篇 |
排序方式: 共有1573条查询结果,搜索用时 13 毫秒
31.
Jeff SW Wong Calvin SH Ng Tak Wai Lee Anthony PC Yim 《Canadian respiratory journal》2006,13(4):219-221
The present report describes a case of severe airway obstruction caused by endobronchial tuberculosis in an 11-year-old girl who was successfully treated by bronchoscopic balloon dilation. This case illustrates the insidious presentation and the increasingly important role of bronchoscopic intervention in the management of endobronchial tuberculosis. In addition, a brief literature review of the condition in the pediatric age group is included. 相似文献
32.
NADPH oxidase is an enzyme in the plasma membrane of the neutrophil that catalyzes the production of O2-, a species central to the oxygen- dependent killing mechanisms of this cell. The oxidase is dormant in resting cells and is activated upon the addition of a stimulus. Neutrophils of patients with chronic granulomatous disease (CGD) manifest no oxidase activity when stimulated. The possible role of protein phosphorylation in the activation of NADPH oxidase was examined in normal and CGD neutrophils by measuring the incorporation of 32Pi into proteins as determined by gel electrophoresis followed by autoradiography. Resting neutrophils from normal subjects exhibit at least 40 distinct phosphoprotein bands. The level of phosphorylation of these bands was examined after the addition of phorbol myristate acetate (PMA), opsonized zymosan, digitonin, N-formyl-methionyl- phenylalanine (FMLP), or NaF. PMA and opsonized zymosan increased the phosphorylation of a set of 6 protein bands. Digitonin and FMLP consistently caused the phosphorylation of 4 of these protein bands, while NaF failed to induce increased phosphorylation of any protein band. All activators tested caused the dephosphorylation of one specific protein band. The time course of phosphorylation (dephosphorylation) was examined using PMA as the activating agent. Increased phosphorylation of one protein band was evident by 12 sec after the addition of PMA. The most slowly phosphorylated protein band did not slow evidence of change until 5 min after the addition of PMA. Three of the phosphoproteins examined were phosphorylated either earlier than or concomitant with the activation of NADPH oxidase. CGD neutrophils were compared with normal cells for their ability to phosphorylate proteins in response to PMA. The phosphoprotein banding patterns of CGD neutrophils were identical with those of normal neutrophils in both the resting and activated states. The evidence presented shows that the phosphorylation of proteins is a prominent feature of neutrophil metabolism. The striking similarity of phosphorylation changes induced by the various activators tested suggests that protein phosphorylation may play a role in some aspects of neutrophil activation. Evidence was not obtained, however, regarding a link between protein phosphorylation and activation of NADPH oxidase. 相似文献
33.
An enzyme-linked immunosorbent assay has been developed for the quantitation of activated Hageman factor-C1 inactivator (HF-C1 INH) complexes. Addition of increasing quantities of either of the major forms of activated Hageman factor (HFa or HFf) to normal plasma or to Hageman factor-deficient plasma leads to a dose-dependent increase in activated HF-C1 INH complexes. As little as 0.5 micrograms/mL of activated HF added to plasma can be detected, corresponding to activation of approximately 2% of plasma HF. The sensitivity of the assay is increased at least tenfold when complexes are formed in HF- deficient plasma, indicating competition between unactivated HF and activated HF-C1 INH complexes for binding to the antibody. Specificity is demonstrated in that addition of activated HF to hereditary angioedema plasma yields less than 1% of the activated HF-C1 INH complex formation obtained with normal plasma. Kaolin activation of HF- deficient plasma yields no detectable complex formation. Kaolin activation of prekallikrein-deficient plasma demonstrates a time- dependent increase in formation of activated HF-C1 INH complex consistent with the ability of HF in this plasma to autoactivate as the time of incubation with the surface is increased. Kaolin treatment of high-molecular weight (HMW) kininogen-deficient plasma yields an even more profound abnormality in the rate of formation of activated HF-C1 INH complexes reflecting the complex role of HMW kininogen in the initiation of contact activation. Although addition of corn inhibitor to plasma prevents activated HF-C1 INH complex formation, it does not inhibit activated HF sufficiently fast to prevent prekallikrein activation. 相似文献
34.
Prevention of degradation of human polymorphonuclear leukocyte proteins by diisopropylfluorophosphate 总被引:27,自引:0,他引:27
Proteases can complicate the characterization of proteins from cells, especially human polymorphonuclear leukocytes (PMN), which contain abundant neutral proteases. We tested the ability of agents to inhibit proteolysis, with special reference to the subunit polypeptides of the contractile proteins actin, myosin, and actin-binding protein (ABP). Phenylmethylsulfonyl fluoride (PMSF), O-phenanthroline, EGTA, EDTA, N- ethylmaleimide, alone or in combinations, failed to prevent extensive proteolysis of the PMN proteins during solubilization of cells with dodecyl sulfate. These inhibitors and also alpha-1-antitrypsin and soybean trypsin inhibitor similarly could not prevent proteolysis during homogenization of cells in cold isosomolar sucrose. Treatment of PMN with greater than or equal to mM diisopropylfluorophosphate (DFP) prior to solubilization or homogenization markedly inhibited proteolysis. PMSF and DFP were equally effective in inhibiting proteolysis in PMN extracts, suggesting that the efficacy of DFP may result from its permeation of intact cells and granules before barriers are disrupted by detergents or homogenization. Treatment of PMN with DFP under conditions inhibiting proteolysis did not affect their rate of phagocytosis. We recommend the use of DFP in future studies correlating functions and protein structure of PMN. 相似文献
35.
In this study we detected a factor that stimulates the proliferation of bone marrow-derived hematopoietic precursors in diffusion chambers implanted in mice. This factor, called diffusible colony-stimulating factor (D-CSF), was found in medium conditioned in the presence of spleen and peripheral blood cells from mice with B cell leukemia (BCL1). After the administration of D-CSF, the number of colonies formed in the plasma clot inside the chamber (CFU-DG) was increased, as were the number of hematopoietic precursors (CFU-MIX, CFU-S, CFU-C, and BFU-E) as judged by a subculture of diffusion chamber contents. Depletion of macrophages and T cells from the spleen cell suspension did not decrease the production of D-CSF, thereby indicating that it was derived from B cells. Neoplastic BCL1 cells appear to be the source because D-CSF could not be detected in medium conditioned with normal B cells. BCL1-conditioned medium (CM) did not enhance CFU-MIX, BFU-E, and CFU-C colony formation in vitro, which suggested that D-CSF is different from multi-CSF, EPA, or CSF. The addition of BCL1 CM to multi- CSF-, erythroid potentiating activity (EPA), and CSF (EL-4CM)- containing cultures had no effect on CFU-MIX, BFU-E, and CFU-C colony formation, thus indicating the absence of a synergistic or inhibitory activity. On the other hand, EL-4 CM, which stimulates CFU-MIX, BFU-E, and CFU-C in vitro, had no effect on CFU-DG in vivo. Biochemical characterization of BCL1 CM revealed that D-CSF is relatively heat stable and loses its bioactivity with protease treatments. It binds to lentil-lectin, according to gel-filtration chromatography has a relative molecular weight of approximately 43,000, and on reverse-phase high-performance liquid chromatography elutes with acetonitrile. These data also indicate that transformed B cells may serve as a source for hematopoietic regulators that act on hematopoietic precursors in vivo. 相似文献
36.
Anthony L Bui Rouselle F Lavado Elizabeth K Johnson Benjamin PC Brooks Michael K Freeman Casey M Graves Annie Haakenstad Benjamin Shoemaker Michael Hanlon Joseph L Dieleman 《Bulletin of the World Health Organization》2015,93(8):566-576D
Objective
To collect, compile and evaluate publicly available national health accounts (NHA) reports produced worldwide between 1996 and 2010.Methods
We downloaded country-generated NHA reports from the World Health Organization global health expenditure database and the Organisation for Economic Co-operation and Development (OECD) StatExtract website. We also obtained reports from Abt Associates, through contacts in individual countries and through an online search. We compiled data in the four main types used in these reports: (i) financing source; (ii) financing agent; (iii) health function; and (iv) health provider. We combined and adjusted data to conform with OECD’s first edition of A system of health accounts manual, (2000).Findings
We identified 872 NHA reports from 117 countries containing a total of 2936 matrices for the four data types. Most countries did not provide complete health expenditure data: only 252 of the 872 reports contained data in all four types. Thirty-eight countries reported an average not-specified-by-kind value greater than 20% for all data types and years. Some countries reported substantial year-on-year changes in both the level and composition of health expenditure that were probably produced by data-generation processes. All study data are publicly available at http://vizhub.healthdata.org/nha/.Conclusion
Data from NHA reports on health expenditure are often incomplete and, in some cases, of questionable quality. Better data would help finance ministries allocate resources to health systems, assist health ministries in allocating capital within the health sector and enable researchers to make accurate comparisons between health systems. 相似文献37.
38.
A series of Ce/SBA-15 catalysts with different degrees of hydrophobicities were prepared via a post-grafting method and used for the direct synthesis of dimethyl carbonate (DMC) from CO2 and methanol. The Ce/SBA-15-6 catalyst exhibited the highest DMC yield of 0.2%, which was close to the equilibrium value under the reaction conditions of 130 °C, 12 h and 12 MPa. The catalysts were characterized via XRD, BET, FT-IR, solid-state 29Si MAS NMR, CA, TEM, XPS and NH3/CO2-TPD; the results indicated that the hydrophobicity of the catalysts facilitated the creation of oxygen vacancies, which could act as Lewis acids to activate methanol. Higher amounts of moderate acid sites led to higher yields of DMC. In addition, the hydrophobicity of the catalysts could also reduce the adsorbed water on their surface and increase the DMC yield while shortening the reaction time.A series of Ce/SBA-15 catalysts with different degrees of hydrophobicities were prepared via a post-grafting method and used for the direct synthesis of dimethyl carbonate (DMC) from CO2 and methanol. 相似文献
39.
目的: 分析广州市耐药结核病患者不良治疗结局状况及其相关影响因素。 方法: 采用回顾性队列研究的方法,从《中国结核病管理信息系统》中导出2016年1月1日至2020年12月31日在广州市胸科医院登记治疗的符合选例要求的677例耐药结核病患者病案数据,分析不良治疗结局的发生情况及其影响因素。 结果: 677例研究对象中,193例(28.5%)治疗成功、280例(41.4%)在治、204例(30.1%)出现了不良治疗结局(包括13例因发生不良反应停止治疗、9例失败、32例死亡、150例失访)。其中,发生不良治疗结局患者的中位生存时间为729d。基于完整数据集的Cox模型多因素分析显示:广州市外户籍、合并糖尿病、省间流动和年龄增长是耐药结核病患者发生不良治疗结局的危险因素[分别为HR(95%CI)=1.74(1.21~2.49),P=0.002;HR(95%CI)=1.59(1.10~2.32),P=0.015;HR(95%CI)=2.29(1.26~4.18),P=0.007;HR(95%CI)=1.01(1.00~1.03),P=0.011],耐多药是保护因素[HR(95%CI)=0.53(0.36~0.79),P=0.002]。 结论: 耐药结核病患者的不良治疗结局发生率较高,应加强对耐药结核病患者的治疗和长期管理,特别是其中合并糖尿病、流动自外省、年龄更大、因户籍所限不能享受本市医疗优惠待遇的患者。 相似文献
40.